BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25599612)

  • 21. Selective Regulation of FGF19 and FGF21 Expression by Cellular and Nutritional Stress.
    Shimizu M; Morimoto H; Maruyama R; Inoue J; Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):154-60. PubMed ID: 26052146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
    Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
    Zhang F; Yu L; Lin X; Cheng P; He L; Li X; Lu X; Tan Y; Yang H; Cai L; Zhang C
    Mol Endocrinol; 2015 Oct; 29(10):1400-13. PubMed ID: 26308386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21.
    Marchelek-Myśliwiec M; Dziedziejko V; Nowosiad-Magda M; Dołęgowska K; Dołęgowska B; Pawlik A; Safranow K; Wiśniewska M; Stępniewska J; Domański M; Ciechanowski K
    Kidney Blood Press Res; 2019; 44(5):1207-1218. PubMed ID: 31614355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition.
    Díaz M; Mestres-Arenas A; Lerin C; Cereijo R; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
    Pediatr Res; 2023 Sep; 94(3):1189-1194. PubMed ID: 37031297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth.
    Ibáñez L; Sebastiani G; Lopez-Bermejo A; Díaz M; Gómez-Roig MD; de Zegher F
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2774-8. PubMed ID: 18460569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal growth and adiposity measurements.
    Díaz M; Campderrós L; Guimaraes MP; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
    Pediatr Res; 2020 Apr; 87(5):897-902. PubMed ID: 31645058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental regulation of the gut-liver (FGF19-CYP7A1) axis in neonates.
    Memon N; Griffin IJ; Lee CW; Herdt A; Weinberger BI; Hegyi T; Carayannopoulos MO; Aleksunes LM; Guo GL
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):987-992. PubMed ID: 30122083
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin, adiponectin, IGFBP-1 levels and body composition in small for gestational age born non-obese children during prepubertal ages.
    Sancakli O; Darendeliler F; Bas F; Gokcay G; Disci R; Aki S; Eskiyurt N
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):88-92. PubMed ID: 18031314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating diazepam-binding inhibitor in infancy: Relation to markers of adiposity and metabolic health.
    Díaz M; Blasco-Roset A; Villarroya J; López-Bermejo A; de Zegher F; Villarroya F; Ibáñez L
    Pediatr Obes; 2021 Nov; 16(11):e12802. PubMed ID: 34014038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans.
    Morville T; Sahl RE; Trammell SA; Svenningsen JS; Gillum MP; Helge JW; Clemmensen C
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age.
    Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; Casano P; de Zegher F
    J Clin Endocrinol Metab; 2009 Mar; 94(3):1049-52. PubMed ID: 19066297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
    Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
    BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin.
    López-Bermejo A; Casano-Sancho P; Fernández-Real JM; Kihara S; Funahashi T; Rodríguez-Hierro F; Ricart W; Ibañez L
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):339-46. PubMed ID: 15355450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins.
    Tyynismaa H; Raivio T; Hakkarainen A; Ortega-Alonso A; Lundbom N; Kaprio J; Rissanen A; Suomalainen A; Pietiläinen KH
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E351-5. PubMed ID: 21123446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity.
    Babaknejad N; Nayeri H; Hemmati R; Bahrami S; Esmaillzadeh A
    Horm Metab Res; 2018 Jun; 50(6):441-452. PubMed ID: 29883971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic change of serum FGF21 levels in response to glucose challenge in human.
    Lin Z; Gong Q; Wu C; Yu J; Lu T; Pan X; Lin S; Li X
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1224-8. PubMed ID: 22539584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
    Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
    Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.
    Lu J; Yu H; Mo Y; Ma X; Hao Y; Lu W; Li H; Bao Y; Zhou J; Jia W
    PLoS One; 2015; 10(11):e0142207. PubMed ID: 26540514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.